Spencer S. Lee Sells 1,500 Shares of Chemed Co. (NYSE:CHE) Stock

Chemed Co. (NYSE:CHE) EVP Spencer S. Lee sold 1,500 shares of the business’s stock in a transaction that occurred on Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the sale, the executive vice president now directly owns 14,627 shares in the company, valued at $8,454,259.73. This trade represents a 9.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Chemed Stock Performance

Shares of CHE stock traded up $0.25 during mid-day trading on Monday, reaching $580.11. 19,972 shares of the company were exchanged, compared to its average volume of 117,674. The business’s 50 day simple moving average is $586.22 and its 200 day simple moving average is $564.37. The company has a market capitalization of $8.49 billion, a P/E ratio of 29.31, a P/E/G ratio of 2.15 and a beta of 0.59. Chemed Co. has a fifty-two week low of $512.12 and a fifty-two week high of $623.60.

Chemed (NYSE:CHE) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts’ consensus estimates of $5.59 by $0.04. Chemed had a net margin of 12.69% and a return on equity of 27.86%. The firm had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. During the same quarter in the previous year, the company posted $5.20 earnings per share. The firm’s revenue was up 9.8% on a year-over-year basis. On average, analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Analysts Set New Price Targets

A number of equities analysts have recently weighed in on CHE shares. Royal Bank of Canada boosted their price target on Chemed from $667.00 to $674.00 and gave the stock an “outperform” rating in a report on Monday, April 28th. StockNews.com raised shares of Chemed from a “hold” rating to a “buy” rating in a research report on Friday, March 7th.

Institutional Trading of Chemed

Several large investors have recently added to or reduced their stakes in CHE. Norges Bank acquired a new position in shares of Chemed during the fourth quarter valued at approximately $95,872,000. GAMMA Investing LLC boosted its position in shares of Chemed by 131,200.8% during the 1st quarter. GAMMA Investing LLC now owns 166,752 shares of the company’s stock valued at $102,606,000 after purchasing an additional 166,625 shares in the last quarter. Freestone Grove Partners LP bought a new stake in shares of Chemed in the 4th quarter worth approximately $61,664,000. Point72 Asset Management L.P. acquired a new stake in Chemed during the fourth quarter valued at approximately $54,587,000. Finally, Fuller & Thaler Asset Management Inc. lifted its stake in Chemed by 249.3% during the first quarter. Fuller & Thaler Asset Management Inc. now owns 130,037 shares of the company’s stock valued at $80,015,000 after purchasing an additional 92,813 shares during the last quarter. 95.85% of the stock is currently owned by institutional investors and hedge funds.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.